ArticleNature communications2026
Embryonic zeolite-mediated suture synthesis of thin and scalable zeolite membranes for tailored gas separation.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Sacrificial Seed Layer Strategy for Hierarchical MFI Zeolite Membranes With Enhanced Butane Isomer Separation Performance.Angewandte Chemie (International ed. in English) · 2026Article
- Zeolite membrane reactors for efficient catalytic conversion of CONational science review · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Zeolite membranes exhibit considerable potential for gas separation; however, two critical challenges (low permeation flux and scaling-up fabrication) continue to hinder their practical implementation. Here, we propose an embryonic zeolite-mediated suture (EZMS) strategy to synthesize large-area zeolite membranes with stable gas separation performance. The membrane thickness is equivalent to that of the initial seed layer-a feature validated across three distinct zeolite frameworks (STT, CHA, and MFI). For high-silica CHA (also known as SSZ-13) zeolite membranes, the EZMS strategy enables a 5-fold thickness reduction, yielding a CO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.